Roundtables: Discussing Regulatory Challenges Across Different Stages of Dry AMD Therapeutics Development
Time: 4:15 pm
day: Day Two
Details:
Some of the biggest challenges when developing drug for dry AMD is understanding the regulatory landscape for all stages of drug development. This session facilitates discussions on a range of regulatory checkpoints including:
- Pre-IND
- Endpoint Designation
- Recruiting & Phase I
- Phase II & Phase III
